dicated that the CDH logistic index was significantly correlated with tumor size and differentiation in ESCC. Conclusion: Both E-cadherin and N-cadherin had a strong expression shift in ESCC compared with non-cancerous tissues. The CDH logistic index, a parameter integrating the expression data of both cadherins, could be used as a marker with high sensitivity and specificity in the identification of ESCC.
Introduction
Esophageal cancer is one of the most prevalent malignancies in the developing countries, especially in Eastern Asia [1, 2] . Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma are the 2 major subtypes of esophageal cancer, and ESCC is the dominant subtype in China [3] . ESCC is associated with an unsatisfactory prognosis and is hard to diagnose at an early stage; thus, once symptom appear, the cancer has often metastasized and progressed to an advance stage [4] . Identification of ESCC at an earlier stage would ultimately improve the prognosis; however, highly sensitive and specific methods to identify ESCC are not yet well established.
For decades, great efforts have been made to develop biomarkers for ESCC, and a large amount of biomarkers has emerged. Mutations, copy number variations, serum proteins, microRNA, and immunohistochemical (IHC) markers have all been well studied Keywords E-cadherin · N-cadherin · ESCC Summary Background: Biomarkers for esophageal squamous cell carcinoma (ESCC) identification with high sensitivity are not well established. Since abnormal expression of cadherins has been widely reported in cancer, we explored its feasibility as an ESCC biomarker. Methods: Expression of E-cadherin and N-cadherin were detected in 150 esophageal tissues by immunohistochemistry. Staining strength and percentage in different subcellular structures of each specimen were evaluated by 2 independent pathologists. A logistic regression-based classifier derived from E-cadherin and N-cadherin staining was generated. Results: E-cadherin exhibited decreased membrane expression in ESCC, while N-cadherin exhibited decreased expression in the nucleus but elevated expression in the cytoplasm. Both E-cadherin and N-cadherin could distinguish ESCC tissues from non-cancerous tissues (area under the curve (AUC) = 0.748, 0.801, respectively). E-cadherin and N-cadherin staining scores could be merged into a cadherin (CDH) logistic index, which showed better discrimination (AUC = 0.909) than E-cadherin or N-cadherin alone. Further investigation in-and have shown promising performance in the identification of ESCC to some extent. Among them, cadherin is a type of calciumdependent adhesion protein which plays an important role in cellcell junction formation. E-cadherin (CDH1) and N-cadherin (CDH2) are the 2 best understood cadherins, affecting cancer progression and metastasis through epithelial-mesenchymal transition (EMT) [5, 6] .
It is already known that increased expression of E-cadherin and decreased expression of N-cadherin are associated with a lower level of malignancy in ESCC [7] . Also, E-cadherin expression was a positive prognostic factor for ESCC, while N-cadherin had the opposite effect [8] . Most previous studies were based on IHC staining which can be substantially affected by subcellular localization. Nevertheless, subcellular localization of E-cadherin and N-cadherin in ESCC, as well as their mutual association, are largely elusive. In this study, IHC staining of E-cadherin and N-cadherin in ESCC were systematically evaluated. Staining strength, stained cell percentage, as well as subcellular localization were carefully reviewed and compared between ESCC tissues and non-cancerous tissues.
Materials and Methods

Patients and Specimen Acquisition
A total of 150 esophageal tissues (75 ESCC and their paired non-cancerous tissues) were purchased from Shanghai Outdo Biotech Co., Ltd. (Shanghai, China). Written informed consent was obtained from all included patients for publication of this study. The study protocol was approved by, and all procedures involving human participants were in accordance with, the ethics committee of Beijing Friendship Hospital, Capital Medical University and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
IHC Staining Procedure
IHC slides were stored at 63 ° C for 1 h, then deparaffinized with xylene for 15 min and consecutively with100% alcohol, 90% alcohol, 80% alcohol, and 70% alcohol for 5 min each. After washing 3 times with pure water for at least 1 min each, slides were immersed in citrate buffer for 5 min at 100 ° C for antigen retrieval and cooled at room temperature for more than 30 min. After goat serum blocking of the non-specific binding site for 30 min, 3% H 2 O 2 was added at room temperature for 10 min, then slides were rinsed 3 times with phosphate-buffered saline (PBS) and incubated with primary antibodies (Cell Signaling Technology, Inc., Danvers, MA, USA) at 4 ° C overnight. After rinsing with PBS, slides were incubated with a secondary biotin-labeled antibody (Cell Signaling Technology) for 10 min. Slides were again washed 3 times with PBS and then subjected to DAB staining (OriGene Wuxi Biotechnology Co., Ltd., Wuxi, China).
IHC Scoring System
Staining results were evaluated by 2 qualified pathologists via light microscopy. Positive staining in the cell membrane, cytoplasm, and nucleus was evaluated separately. Staining strength was defined as: 0, no specific staining at all; 1, weak; 2, moderate; and 3, strong staining. Staining percentage or extent was calculated by randomly observing 3 high-power fields with 100 epithelial cells counted in each. The staining score was defined as staining strength multiplied by staining percentage.
Statistical Analysis
All statistical analyses were performed using SPSS, version 19.0 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation, and categorical variables as frequency and percentage. Logistic regression and ROC cure were applied to calculate the area under the curve (AUC) and the p value; p 0.05 was considered as statistically significant. 
Results
Expression of E-Cadherin in ESCC Tissues and Paired Non-Cancerous Tissues
Expression of E-cadherin in both the membrane and the cytoplasm in all 75 pairs of tissues was evaluated (no staining in the nucleus was observed). The basic clinicopathological characteristics of the 75 ESCC patients are listed in table 1. Representative IHC staining results of ESCC tissues and their paired non-cancerous tissues are shown in figure 1A . When combining staining strength with staining percentage, the generated staining score displayed a marginally significant statistical difference between ESCC and normal esophageal tissues (0.82 ± 0.76 vs. 0.61 ± 0.51; p = 0.053 ( fig. 1B, supplemental table 1 ). In terms of membrane expression, E-cadherin staining strength (p = 0.002) and percentage (p < 0.001) were much more obvious in normal esophageal tissues, and the staining score also showed significant differences (0.29 ± 0.50 vs. 0.86 ± 0.89; p < 0.001) (fig. 1C ). In conclusion, E-cadherin was mainly located on the membrane in normal esophageal tissues, while it was translocated from the membrane to the cytoplasm in ESCC tissues.
Expression of N-Cadherin in ESCC Tissues and Paired Non-Cancerous Tissues
Positive staining of N-cadherin was observed in both the cytoplasm and the nucleus of both ESCC and non-cancerous tissues. Representative IHC staining results of ESCC tissues and their paired non-cancerous tissues are shown in figure 2A . In ESCC tissues, cytoplasmic N-cadherin expression was more obvious compared to normal esophageal tissues. IHC staining strength (p = 0.002), staining percentage (p < 0.001), and staining score (0.88 ± 0.62 vs. 0.34 ± 0.32; p < 0.001) of cytoplasmic N-cadherin all exhib-
Generation of a CDH Logistic Index to Distinguish ESCC
A CDH2 staining index was defined as N-cadherin's cytoplasm staining score minus the nucleus staining score, which was much higher in ESCC tissues than in paired non-cancerous tissues ( fig. 4A ) and proofed promising for the classification of ESCC tissues and paired non-cancerous tissues (AUC 0.881, 95% CI 0.824-0.938; p < 0.001) ( fig. 4B ). E-cadherin and N-cadherin expression were associated with each other. According to our IHC results, the E-cadherin membrane staining score was negatively correlated with the N-cadherin cytoplasm staining score (R = 0.316; p < 0.001) ( fig. 4C ). Information on a total of 98 ESCC tissues was downloaded from The Cancer Genome Atlas (TCGA) for further validation, which revealed a significant inverse correlation between E-cadherin and N-cadherin also on the transcript level (R = 0.320; p < 0.001) ( fig. 4D ). Based on a linear logistic regression model, we combined the CDH2 staining index with the E-cadherin membrane staining score to generate a cadherin (CDH) logistic index (4.6486*CDH2_index-2.6588*CDH1_membrane_staining_score-1.10309). The CDH logistic index was significantly higher in ESCC ( fig. 4E ) and exerted the highest discriminatory power for distinguishing between ESCC tissues and non-cancerous tissues (AUC 0.909, 95% CI 0.862-0.957; p < 0.001) ( fig. 4F) . 2B ). In conclusion, Ncadherin was mainly located in the nucleus of normal esophageal tissues, while it was translocated from the nucleus to the cytoplasm in ESCC tissue.
Expression of E-Cadherin or N-Cadherin Could Distinguish ESCC from Non-Cancerous Tissues
The AUC of the membrane E-cadherin staining percentage to distinguish ESCC from non-cancerous tissues was found to be 0.776 (95% confidence interval (CI) 0.701-0.851; p < 0.001) ( fig. 3A) , indicating modest discriminatory power. When combining staining percentage with staining strength, the IHC membrane staining score of E-cadherin failed to show better discrimination (AUC 0.748, 95% CI 0.670-0.827; p < 0.001) ( fig. 3B) 
Correlation between CDH Logistic Index and Other Clinical Parameters
Basic clinicopathological data are shown in table 1. Further analysis of these clinical parameters revealed that poorly differentiated (grade 3) ESCC tissues had a significantly higher CDH logistic index than moderately and well differentiated (grade 2/1) ESCC tissues (grade 3 vs. grade 1: 3.81± 3.83 vs. 1.64 ± 1.66; p < 0.001) ( fig. 5A) . Additionally, ESCC tissues with small tumor size had a significantly higher CDH logistic index than those with large tumor size (< 4 vs. 6 cm: 3.43 ± 3.71 vs. 1.84 ± 3.24; p < 0.001) ( fig. 5B ).
Discussion
Cadherin is a family of transmembrane proteins critical for cellcell junction, cell polarity, and normal cell structure maintenance [5] . Among the cadherin family members, E-cadherin and N-cadherin have been reported to be related to tumorigenesis, and their functions are well studied [9, 10] . It is extensively accepted that during oncogenesis epithelial cells express cadherin aberrantly and experience EMT [11, 12] .
Knockdown of N-cadherin in ESCC cell lines can induce cell apoptosis and reduce invasiveness in vitro [13] . In contrast, downregulation of E-cadherin increased the invasive ability of ESCC cells [8] . Similar results were found in colorectal cancer [14] , head and neck squamous cell carcinoma [15] , and gastric cancer [16] . In this study, we revealed that E-cadherin's translocation from the membrane to the cytoplasm and N-cadherin's translocation from the nucleus to the cytoplasm may occur during carcinogenesis of ESCC, suggesting the potential of cadherins to be used as biomarkers and therapeutic targets. Nevertheless, more detailed functional analysis in different subcellular structures was needed to elucidate the mechanisms underlying these phenomena. Several studies have demonstrated that during tumor development from normal cell, to dysplasia, to cancer cell, E-cadherin expression gradually declines while N-cadherin expression increases [17, 18] . One such study even perceived a double-negative expression phase of E-cadherin and N-cadherin in bladder transitional cell carcinoma, suggesting an EMT process [19] . In our study, expression of these 2 cadherins was found to be negatively correlated, which is in line with previous research. Considering this association between E-cadherin and N-cadherin, we combined the 2 markers in a logistic model and generated a new parameter, the CDH logistic index. The CDH logistic index exhibited powerful discrimination in distinguishing ESCC from non-cancerous esophageal tissues.
Decreased expression of E-cadherin was associated with poor tumor differentiation in gastric cancer [16] and infiltrative tumor growth pattern in colorectal cancer [20] . In our study, the CDH logistic index was significantly associated with tumor differentiation and tumor size. Representatively, a tumor smaller than 4 cm with poor differentiation was most likely to receive a higher CDH logistic index. Considering that smaller and poorly differentiated tumors always have a poor prognosis, it could be expected that the CDH logistic index is of potential prognostic value in ESCC. However, due to the limited clinical information, the prognostic potential of the CDH logistic index requires further exploration.
In conclusion, both E-cadherin and N-cadherin had a strong expression shift in different subcellular organelles in ESCC compared with non-cancerous tissues. The CDH logistic index, a parameter generated by integrating the expression of both cadherins, could be used as a marker with high sensitivity and high specificity in the identification of ESCC.
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